Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-15

FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOSTRICT (vasopressin)

Snippet

SUPPL AP for VASOSTRICT (VASOPRESSIN)